par Orlent, Hans;Reynaert, Hendrik;Bourgeois, Stefan;Dideberg, Vinciane;Adler, Michael 
;Colle, Isabelle;De Maeght, S;Laleman, Wim;Michielsen, Peter;Moreno, Christophe ;Mulkay, Jean-Pierre ;Starkel, Peter;Delwaide, Jean;Belgian Association for the Study of the Liver,
Référence Acta gastro-enterologica Belgica (Ed. multilingue), 74, 2, page (317-322)
Publication Publié, 2011-06
;Colle, Isabelle;De Maeght, S;Laleman, Wim;Michielsen, Peter;Moreno, Christophe ;Mulkay, Jean-Pierre ;Starkel, Peter;Delwaide, Jean;Belgian Association for the Study of the Liver, Référence Acta gastro-enterologica Belgica (Ed. multilingue), 74, 2, page (317-322)
Publication Publié, 2011-06
Article révisé par les pairs
| Résumé : | Polymorphisms in the region of the interleukin-28B (IL28B) gene have recently been associated with spontaneous and treatment induced clearance of hepatitis C virus infection. The specific mechanisms of how IL28B polymorphisms affect HCV suppression remain unknown. It is a matter of ongoing debate how to incorporate the IL28B data into the current treatment algorithms with pegylated interferon-alpha and ribavirin. The eventual role of the IL28B genotype in new therapeutic regimes with direct antiviral agents needs to be explored in the ongoing and future clinical studies with these agents. |
